Tanabe Seiyaku Hanbai

Nipro Tanabe Pharma, formerly known as Tanabe Seiyaku Hanbai, is a Japanese pharmaceutical company specializing in the manufacture and sale of generic drugs. Originally a subsidiary of Mitsubishi Tanabe Pharma, the company was acquired by Nipro Corporation in 2017 to strengthen Nipro's generic drug business. The company provides a wide range of high-quality generic medications across various therapeutic areas, including cardiovascular, gastrointestinal, and metabolic diseases. It leverages the manufacturing expertise of the Nipro Group to ensure a stable supply of essential medicines to the Japanese healthcare market. The company is headquartered in Osaka and operates as a key component of Nipro's domestic pharmaceutical strategy.